Improve posture and trunk flexibility
- Trial ID
- NCT06536478
- Official Title
- The Effect of Exercise Intervention on Posture, Trunk Flexibility and Spine Function in Patients With Parkinson's Disease
- Goal
- Improve posture and trunk flexibility
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- National Taiwan University Hospital
- Study Type
- INTERVENTIONAL
- Enrollment
- 40 participants
- Conditions
- Parkinson Disease
- Interventions
- exercise, education
Plain-Language Summary
It aims to reduce stooped posture and improve trunk flexibility and spine function in Parkinson's, which can ease back pain and help balance. The program uses supervised exercise plus education that focuses on strengthening back extensor and core muscles, stretching tight trunk muscles, posture training, and mobility drills to increase spinal range of motion and teach safer alignment during daily activities. Because it is a non-drug intervention, it does not change how levodopa works; instead it targets the muscle weakness and stiffness that medications usually do not fix. The trial is looking for people aged 30 to 85 with Parkinson's at Hoehn and Yahr stage 2 to 3 who are medically stable, able to follow instructions, and compliant with medications, excluding those with dementia, recent musculoskeletal injuries or surgery, cardiopulmonary limits, or acute neurological problems.
Locations
- National Taiwan University Hospital Hsinchu Branch, Hsinchu, Taiwan
Frequently Asked Questions
- What is this trial testing?
- This trial is studying exercise. It aims to reduce stooped posture and improve trunk flexibility and spine function in Parkinson's, which can ease back pain and help balance. The program uses supervised exercise plus education that focuses on strengthening back extensor and core muscles, stretching tight trunk muscles, posture training, and mobility drills to increase spinal range of motion and teach safer alignment during daily activities. Because it is a non-drug intervention, it does not change how levodopa works; instead it targets the muscle weakness and stiffness that medications usually do not fix. The trial is looking for people aged 30 to 85 with Parkinson's at Hoehn and Yahr stage 2 to 3 who are medically stable, able to follow instructions, and compliant with medications, excluding those with dementia, recent musculoskeletal injuries or surgery, cardiopulmonary limits, or acute neurological problems.
- Who can participate?
- Participants must be between 30 Years and 85 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 2 years and 10 months.